Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Tirofiban | Tirofiban Impurity A | VL2720001 | View CAS 149490-60-8 |
Tirofiban | Tirofiban Impurity B | VL2720002 | View CAS 149463-65-0 |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Tirofiban | Tirofiban Impurity A | VL2720001 | View CAS 149490-60-8 |
Tirofiban | Tirofiban Impurity B | VL2720002 | View CAS 149463-65-0 |
Catalogue No. | VL2720002 |
CAS No. | 149463-65-0 |
Molecular Formula | C9H13Cl2N |
Molecular Weight | 206.11 |
Parent drug | Tirofiban |
IUPAC Name | 4-(4-chlorobutyl)pyridine Hydrochloride |
Synonyms | N/A |
References | Sci-Hub, Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials, 10.1093/eurheartj/ehp376. (2022). Retrieved January 28, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1093/eurheartj/ehp376 ? |
Status | In-stock |
ListName | Tirofiban Impurity B |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields